Eloxx Pharmaceuticals Inc: Zkn-013 Has Been Exclusively Licensed to Almirall, S.A. Who Has Global Rights to Develop and Commercialize Zkn-013
eloxx pharmaceuticals已将Zkn-013的独家许可授权给Almirall,S.A.,后者全球拥有开发和商业化Zkn-013的权利
Eloxx Pharmaceuticals Inc: Zkn-013 Has Been Exclusively Licensed to Almirall, S.A. Who Has Global Rights to Develop and Commercialize Zkn-013
eloxx pharmaceuticals已将Zkn-013的独家许可授权给Almirall,S.A.,后者全球拥有开发和商业化Zkn-013的权利
译文内容由第三方软件翻译。